Long Term Care Account Specialist - Boise, ID

Knowledge of CMS guidelines affecting psychotropic medication use in skillednursing facilities Neurocrine Biosciences... including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades...

Lugar: Boise, ID | 08/01/2026 22:01:20 PM | Salario: S/. $123100 - 168000 per year | Empresa: Neurocrine Biosciences

Long Term Care Account Specialist - Tulsa OK

Knowledge of CMS guidelines affecting psychotropic medication use in skillednursing facilities Neurocrine Biosciences... including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades...

Lugar: Tulsa, OK | 20/12/2025 02:12:07 AM | Salario: S/. $120600 - 165000 per year | Empresa: Neurocrine Biosciences

Long Term Care Account Specialist - Richmond VA

Knowledge of CMS guidelines affecting psychotropic medication use in skillednursing facilities Neurocrine Biosciences... including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades...

Lugar: Richmond, VA | 20/12/2025 02:12:02 AM | Salario: S/. $120600 - 165000 per year | Empresa: Neurocrine Biosciences

Long Term Care Account Specialist - Erie PA

Knowledge of CMS guidelines affecting psychotropic medication use in skillednursing facilities Neurocrine Biosciences... including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades...

Lugar: Erie, PA | 20/12/2025 01:12:02 AM | Salario: S/. $120600 - 165000 per year | Empresa: Neurocrine Biosciences

Long Term Care Account Specialist - Wichita KS

Knowledge of CMS guidelines affecting psychotropic medication use in skillednursing facilities Neurocrine Biosciences... including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades...

Lugar: Wichita, KS | 19/12/2025 23:12:19 PM | Salario: S/. $120600 - 165000 per year | Empresa: Neurocrine Biosciences